Handbook · Part VI · Chapter 18
Platform Ingredient Atlas
Every ingredient of the SIRIAM Platform is documented once, in one format, and referenced by every formulation that uses it.
Ingredient information is never duplicated inside a product record. A formulation links to the sheet; the sheet remains the single source of truth.
18-001
MSM
MSM (Methylsulfonylmethane)
Structural & Dermal Support Core · Evidence B–C
18-002
Magnesium Chloride
Magnesium Chloride (MgCl₂)
Structural & Dermal Support Core · Evidence B–C
18-003
D-Panthenol
D-Panthenol (Provitamin B5)
Structural & Dermal Support Core · Evidence A–B
18-004
Vitamin E
Full Spectrum Natural Vitamin E (Mixed Tocopherols)
Structural & Dermal Support Core · Evidence A–B
18-005
Silicea Gel
Silicea Gel (Colloidal Silica Gel)
Structural & Dermal Support Core · Evidence B–C
18-006
Copaiba Oil
Copaiba Oil (Copaifera spp.)
Structural & Dermal Support Core · Evidence B
18-007
PEA
Palmitoylethanolamide (PEA)
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-008
Boswellia serrata
Boswellia serrata Extract
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-009
Ruta graveolens
Ruta graveolens Extract
Release Core · Evidence C
18-010
Arnica montana
Arnica montana Extract
Release Core · Evidence A–B (topical evidence)
18-011
Ginkgo biloba
Ginkgo biloba Leaf Extract
Release Core · Evidence A–B (oral evidence); C (topical evidence)
18-012
Bacopa monnieri
Bacopa monnieri Extract
Integration Core · Evidence A–B (oral evidence); C (topical evidence)
18-013
Blue Lotus
Nymphaea caerulea (Blue Lotus) Extract
Integration Core · Evidence C–D
18-014
Betaine (TMG)
Betaine (Trimethylglycine, TMG)
Integration Core · Evidence A (physiological and oral evidence); B (topical dermatological evidence)
18-015
Niacinamide
Niacinamide (Vitamin B3)
Integration Core · Evidence A
18-016
Melissa officinalis
Melissa officinalis Extract (Lemon Balm)
Regional Signature Components · Evidence A–B (herpes topical evidence); B (oral evidence); C (regional neurodermal application)
18-017
Gelsemium sempervirens
Gelsemium sempervirens
Regional Signature Components · Evidence D
18-018
Rhodiola rosea
Rhodiola rosea Extract
Regional Signature Components · Evidence A–B (oral evidence); C (topical evidence)
18-019
Hypericum perforatum
Hypericum perforatum Extract (St. John's Wort)
Regional Signature Components · Evidence A (oral evidence); A–B (topical wound-healing evidence); C (regional neurodermal application)
18-020
Chelidonium majus
Chelidonium majus Extract (Greater Celandine)
Regional Signature Components · Evidence B–C (topical dermatological evidence); C (experimental evidence); C–D (regional neurodermal application)
18-021
Frankincense
Frankincense (Boswellia carterii / Boswellia sacra Essential Oil)
Regional Signature Components · Evidence B–C
18-022
Myrrh
Myrrh (Commiphora myrrha Essential Oil / Resin Extract)
Regional Signature Components · Evidence B–C
18-023
Carbo vegetabilis
Carbo vegetabilis
Regional Signature Components · Evidence D
18-024
α-Bisabolol
α-Bisabolol (Levomenol)
Regional Signature Components · Evidence A–B
18-025
Syn®-Ake
Syn®-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Regional Signature Components · Evidence B (cutaneous topical evidence); C (experimental neurophysiology); C (regional neurodermal application)
18-026
Solidago virgaurea
Solidago virgaurea Extract (Goldenrod)
Regional Signature Components · Evidence B (oral evidence); C (topical evidence); C (regional neurodermal application)
18-027
Berberis vulgaris
Berberis vulgaris Extract (Barberry)
Regional Signature Components · Evidence A–B (oral berberine evidence); C (topical evidence); C (regional neurodermal application)
18-028
Castor Oil
Castor Oil (Ricinus communis Seed Oil)
Regional Signature Components · Evidence A–B
18-029
Squalane
Squalane
Regional Signature Components · Evidence A
18-030
Sepia officinalis
Sepia officinalis
Regional Signature Components · Evidence D
18-031
Staphysagria
Staphysagria (Delphinium staphisagria)
Regional Signature Components · Evidence D
18-032
Aesculus hippocastanum
Aesculus hippocastanum Extract (Horse Chestnut)
Regional Signature Components · Evidence A–B (oral vascular evidence); B (topical evidence); C (regional neurodermal application)
18-033
Magnesium Bisglycinate
Magnesium Bisglycinate
Regional Signature Components · Evidence A (oral evidence); C (topical evidence); C (regional neurodermal application)
18-034
Coenzyme Q10
Coenzyme Q10 (Ubiquinone)
Regional Signature Components · Evidence A (oral evidence); A–B (topical dermatological evidence); C (regional neurodermal application)
18-035
Taurine
Taurine
Regional Signature Components · Evidence A (oral physiological evidence); B (topical dermatological evidence); C (regional neurodermal application)
Structural & Dermal Support Core
18-001
MSM
MSM (Methylsulfonylmethane)
Evidence B–C
18-002
Magnesium Chloride
Magnesium Chloride (MgCl₂)
Evidence B–C
18-003
D-Panthenol
D-Panthenol (Provitamin B5)
Evidence A–B
18-004
Vitamin E
Full Spectrum Natural Vitamin E (Mixed Tocopherols)
Evidence A–B
18-005
Silicea Gel
Silicea Gel (Colloidal Silica Gel)
Evidence B–C
18-006
Copaiba Oil
Copaiba Oil (Copaifera spp.)
Evidence B
Release Core
18-007
PEA
Palmitoylethanolamide (PEA)
Evidence A–B (oral evidence); C (topical evidence)
18-008
Boswellia serrata
Boswellia serrata Extract
Evidence A–B (oral evidence); C (topical evidence)
18-009
Ruta graveolens
Ruta graveolens Extract
Evidence C
18-010
Arnica montana
Arnica montana Extract
Evidence A–B (topical evidence)
18-011
Ginkgo biloba
Ginkgo biloba Leaf Extract
Evidence A–B (oral evidence); C (topical evidence)
Integration Core
18-012
Bacopa monnieri
Bacopa monnieri Extract
Evidence A–B (oral evidence); C (topical evidence)
18-013
Blue Lotus
Nymphaea caerulea (Blue Lotus) Extract
Evidence C–D
18-014
Betaine (TMG)
Betaine (Trimethylglycine, TMG)
Evidence A (physiological and oral evidence); B (topical dermatological evidence)
18-015
Niacinamide
Niacinamide (Vitamin B3)
Evidence A
Regional Signature Components
18-016
Melissa officinalis
Melissa officinalis Extract (Lemon Balm)
Evidence A–B (herpes topical evidence); B (oral evidence); C (regional neurodermal application)
18-017
Gelsemium sempervirens
Gelsemium sempervirens
Evidence D
18-018
Rhodiola rosea
Rhodiola rosea Extract
Evidence A–B (oral evidence); C (topical evidence)
18-019
Hypericum perforatum
Hypericum perforatum Extract (St. John's Wort)
Evidence A (oral evidence); A–B (topical wound-healing evidence); C (regional neurodermal application)
18-020
Chelidonium majus
Chelidonium majus Extract (Greater Celandine)
Evidence B–C (topical dermatological evidence); C (experimental evidence); C–D (regional neurodermal application)
18-021
Frankincense
Frankincense (Boswellia carterii / Boswellia sacra Essential Oil)
Evidence B–C
18-022
Myrrh
Myrrh (Commiphora myrrha Essential Oil / Resin Extract)
Evidence B–C
18-023
Carbo vegetabilis
Carbo vegetabilis
Evidence D
18-024
α-Bisabolol
α-Bisabolol (Levomenol)
Evidence A–B
18-025
Syn®-Ake
Syn®-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate)
Evidence B (cutaneous topical evidence); C (experimental neurophysiology); C (regional neurodermal application)
18-026
Solidago virgaurea
Solidago virgaurea Extract (Goldenrod)
Evidence B (oral evidence); C (topical evidence); C (regional neurodermal application)
18-027
Berberis vulgaris
Berberis vulgaris Extract (Barberry)
Evidence A–B (oral berberine evidence); C (topical evidence); C (regional neurodermal application)
18-028
Castor Oil
Castor Oil (Ricinus communis Seed Oil)
Evidence A–B
18-029
Squalane
Squalane
Evidence A
18-030
Sepia officinalis
Sepia officinalis
Evidence D
18-031
Staphysagria
Staphysagria (Delphinium staphisagria)
Evidence D
18-032
Aesculus hippocastanum
Aesculus hippocastanum Extract (Horse Chestnut)
Evidence A–B (oral vascular evidence); B (topical evidence); C (regional neurodermal application)
18-033
Magnesium Bisglycinate
Magnesium Bisglycinate
Evidence A (oral evidence); C (topical evidence); C (regional neurodermal application)
18-034
Coenzyme Q10
Coenzyme Q10 (Ubiquinone)
Evidence A (oral evidence); A–B (topical dermatological evidence); C (regional neurodermal application)
18-035
Taurine
Taurine
Evidence A (oral physiological evidence); B (topical dermatological evidence); C (regional neurodermal application)